⬅ Back to All Recalls

Sucralfate Tablets USP 1 gram Recall Due to Company closure and discontinuati...

# Major Recall Alert: Sucralfate Tablets USP 1 Gram Recalled Due to Company Closure and Discontinuation of Quality Activities

The pharmaceutical industry is facing yet another recall alert. **Nostrum Laboratories, Inc.** has announced the voluntary nationwide recall of **Sucralfate Tablets USP 1 gram** due to the company's closure and its subsequent inability to guarantee the product meets quality standards. If you or someone you know uses this medication, read on to understand the scope of this recall and the actions you should take.

## Why This Recall is Important

Safety is paramount when it comes to medication. With the closure of Nostrum Laboratories following its Chapter 11 bankruptcy filing on **September 30, 2024**, the company has ceased all operations and terminated its quality assurance program. As a result, the affected **Sucralfate Tablets USP 1 gram** may not meet the necessary identity, strength, quality, and purity standards required for safe use, even if the product remains within expiry.

This situation could potentially pose a risk to patient health. While no adverse event reports have been received to date, the lack of guaranteed quality raises concerns regarding patient safety. The U.S. FDA is aware of and coordinating this voluntary recall, underscoring its importance.

## Details of the Recall

Here’s what you need to know about this significant recall from Nostrum Laboratories:

- **Product Name**: Sucralfate Tablets USP 1 gram
- **Reason for Recall**: Nostrum Labs’ closure and discontinuation of quality assurance activities
- **Affected Lots**: All lots manufactured after **June 2023**, within expiry
- **Distribution**: The product was sent to wholesalers, retailers, manufacturers, medical facilities, and repackagers across the U.S.
- **Customer Notification**: Nostrum Labs is informing distributors and direct consignees via email and U.S. mail, requesting that the information be shared with downstream customers, retailers, and consumers.

### Is Your Product Affected?

This recall is **limited solely to Sucralfate Tablets USP 1 gram** manufactured after June 2023. No other Nostrum Laboratories products are impacted by this action. If you have this product in your medicine cabinet, stop using it immediately and follow the company’s instructions to ensure proper disposal.

For the **official source**, visit the FDA announcement:
[FDA Recall Alert](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/nostrum-laboratories-inc-issues-voluntary-nationwide-recall-sucralfate-tablets-usp-1-gram-within)

## What You Should Do

Consumers, healthcare providers, and distributors are encouraged to take immediate action:

- **Stop Using the Product**: Cease the use or distribution of Sucralfate Tablets USP 1 gram.
- **Dispose Properly**: All lots of this product within expiry should be destroyed as per industry standards.
- **Consult Your Physician**: If you’ve taken the affected product and are concerned about side effects or related issues, contact your healthcare provider.
- **Report Any Issues**: Adverse effects or quality problems can be reported to the **FDA’s MedWatch Adverse Event Reporting program** either online, by mail, or by fax.

For specific questions related to the recall, you can contact Nostrum Labs directly via email at **recallcoordinator@nostrumlabsrecall.com**.

## Stay Safe – Get Instant Recall Alerts

Recalls like this one can happen without warning, but staying updated could make the difference in safeguarding your health. Download our free app today to receive **instant recall alerts** for pharmaceutical products, food, and other essential categories. Protect yourself and your loved ones with real-time safety notifications at your fingertips.

**Stay informed, stay safe, and stay ahead.**

Don’t let medication recalls catch you off guard. For more information on this and other safety updates, visit the **FDA Recall Alert page** linked [here](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/nostrum-laboratories-inc-issues-voluntary-nationwide-recall-sucralfate-tablets-usp-1-gram-within).

**Download the app now and take control of your safety alerts.**

⬅ Back to All Recalls